Vaxigrip And Fluzone Flu Vaccines Not Associated With Reported Adverse Events In Canada
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Vaxigrip And Fluzone Flu Vaccines Not Associated With Reported Adverse Events In Canada

TORONTO, ON -- November 8, 2000 -- Health Canada has advised Aventis Pasteur Limited and provincial health authorities that since October, the vaccine surveillance system has received reports of 117 mild adverse events (red eyes and respiratory symptoms that disappeared in 48 hours) following flu shots administered in British Columbia, Manitoba, Newfoundland, Alberta, and Quebec.

Aventis Pasteur Limited confirms that its influenza vaccines, Vaxigrip® and Fluzone®, are not distributed to provincial immunization programs in the above-mentioned provinces and are not associated with these adverse events.

Aventis Pasteur Limited, Canada's largest distributor of influenza vaccine, has contracted to supply 8.3 million doses of vaccines through provincial immunization programs in Ontario, Nova Scotia, New Brunswick, Saskatchewan, Nunavut and the North West Territories. Another manufacturer distributes flu vaccine to provincial immunization programs in the remaining provinces and territory.

Following the distribution of over five million doses of Aventis Pasteur flu vaccines so far this year in Canada, and tens of millions of doses in the United States and throughout the world, none of these adverse events confirmed by Health Canada have been observed following administration of Vaxigrip® or Fluzone®.

Canadians at risk for influenza are encouraged to be vaccinated to effectively prevent this disease. While the vast majority of people have no side-effects after receiving a flu shot, some may experience minor pain or swelling at the injection site. A few may experience mild fever and achiness within 24 to 48 hours of receiving their shot. Influenza is a serious and life-threatening illness. The risk of disease far outweighs the risk associated with immunization.

Related Link: Aventis Pasteur Limited.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities